Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease - Wikidata - wikimedia - TriplyDB

Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease

Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease

http://www.wikidata.org/entity/Q33591146

about

Modeling and Classification of Kinetic Patterns of Dynamic Metabolic Biomarkers in Physical Activity Serum levels of WNT1-inducible signaling pathway protein-1 (WISP-1): a noninvasive biomarker of renal fibrosis in subjects with chronic kidney disease.From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action.Multimarker proteomic profiling for the prediction of cardiovascular mortality in patients with chronic heart failure Nuclear Magnetic Resonance Metabolomic Profiling of Mouse Kidney, Urine and Serum Following Renal Ischemia/Reperfusion Injury Biomarkers in Transplantation--Proteomics and Metabolomics.Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease.Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.Advances in urinary proteome analysis and applications in systems biology.Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.Proteomic biomarkers in kidney disease: issues in development and implementation.Analytical approaches to the diagnosis and treatment of aging and aging-related disease: redox status and proteomics.Body fluid peptide and protein signatures in diabetic kidney diseases.Physiological conditions can be reflected in human urine proteome and metabolome.Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome.Metabolomics for clinical use and research in chronic kidney disease.Proteomics in cardiovascular disease: recent progress and clinical implication and implementation.PeptiCKDdb-peptide- and protein-centric database for the investigation of genesis and progression of chronic kidney disease.Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus.Detection of urinary biomarkers in reservoir hosts of leptospirosis by capillary electrophoresis-mass spectrometry.Metabolomic Modularity Analysis (MMA) to Quantify Human Liver Perfusion Dynamics.Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients.Feline urine metabolomic signature: characterization of low-molecular-weight substances in urine from domestic cats.Medium- and long-chain acylcarnitines are associated with osteoarthritis severity and arterial stiffness in end-stage osteoarthritis patients: a case-control study.Association Between Newborn Metabolic Profiles and Pediatric Kidney Disease.

P2860

Q28387059-458855DD-D325-4C12-988F-F07D710382D5 Q33850279-55C65BA5-9967-4A9E-999D-D30F2FB16980 Q34391213-3F2F276B-CAA7-4BA1-9067-0D1E1066752A Q35532994-E838ED68-1CE4-47A1-B120-C04566DC3CCF Q36140947-A21388DE-3745-44F0-A6F0-50962AA961F3 Q36627136-5E652870-2613-4BEE-BC74-8D98C126AC27 Q36910790-F2A4754B-D830-4255-BA03-3BF358AAE84D Q37271191-AE7B503A-E45F-4CC4-9654-6F2E12152523 Q37724958-90FB192B-3D7E-441E-957E-F3226E6D60AC Q38269864-8EBA5886-C4AE-4DB4-8317-901CFC94AFB5 Q38340351-06DCF17B-3E0C-4AB6-AE6B-5C14CF101DAA Q38341211-F676E418-9A03-491A-827C-BF59DC250B3E Q38396814-0E50B940-80ED-44FD-94FA-B4DF62316CFE Q38553924-BC9F8149-D636-4823-BDEC-E10D7A49B4D0 Q38608509-8DFD3D49-465F-410C-B535-96951871316F Q38646836-CC56413F-8289-47BA-BB67-DB2DB0532919 Q38750287-85F968B0-79D8-4674-9E20-31209CAC866B Q38780174-190271D0-BB35-43F8-AE7F-D77156FFFCE9 Q39427509-9955520E-1F9C-4A49-99C4-B008E1A48AD8 Q39631863-56C00AE9-04AB-4B35-B274-48F0000E5687 Q41305926-1AC1297D-5CE4-46B1-8330-592750207DAF Q46011126-12AEB503-DA47-44C3-A640-135933F1697C Q46673943-558F2041-F4DC-439C-8B8B-222B3A11A422 Q47224149-B3D6AC42-AE93-40C4-8A74-D5CA815ABA28 Q48285032-8C0C51D2-3F4B-4BB4-8D03-B63B6DC47C14 Q55092989-0EF419AF-EAE7-4983-B276-C79572EB5474

P2860

Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease

http://www.wikidata.org/entity/Q33591146

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Assessment of metabolomic and ...... tion in chronic kidney disease

@ast

Assessment of metabolomic and ...... tion in chronic kidney disease

@en

type

label

Assessment of metabolomic and ...... tion in chronic kidney disease

@ast

Assessment of metabolomic and ...... tion in chronic kidney disease

@en

prefLabel

Assessment of metabolomic and ...... tion in chronic kidney disease

@ast

Assessment of metabolomic and ...... tion in chronic kidney disease

@en

P1433

Q33591146-7A316361-C701-4FAB-97E0-0C782DE9D992

P1476

Q33591146-7F828CEB-BB76-433A-9B83-C7C242356D1D

P2093

Q33591146-2A3469E4-2274-42B6-BB3F-57301224750B

Q33591146-41A2A3AE-24EC-4C75-BF51-F4EB1C1BE485

Q33591146-6317EFD4-F89F-44AA-BB62-9A49B409488F

Q33591146-6CAEEB98-854B-4C76-AF46-AC522A318E37

Q33591146-CB6A2D46-15FB-4632-AD0F-09FD402AF94F

Q33591146-D049CDE5-79E1-4AD6-A35C-317D1D1601BB

Q33591146-E9288C00-1BE4-4C61-86FB-8AEFC7885D3B

Q33591146-F9F83110-5B27-4EF0-982A-BB548410FE16

P2860

Q33591146-06825BA6-813A-47B9-A2BD-DFEC0759C5CA

Q33591146-08A270F8-9334-425A-ABEC-D747B533DB9C

Q33591146-1012B31B-E4CD-4C48-B8DB-39F542844167

Q33591146-139F8E13-8EB1-4C1E-A0A7-37CFFC485760

Q33591146-18CE48FD-2D3B-4901-881D-FC0158BDD3EE

Q33591146-1931D392-9D86-45FE-BA81-DF5F3B16BD50

Q33591146-1D05AE2D-9102-4B6A-907F-34998A57014D

Q33591146-20CF87AB-42C6-49B1-BA8F-38EFB4A5E695

Q33591146-2248D3E0-177D-4861-A50E-1CDCF1D02969

Q33591146-23D882C1-F362-4788-BD50-7964BE3670B9

P304

Q33591146-FF8A0E56-D00D-423C-8C79-709079C81636

P31

Q33591146-EFB9EA17-F2C5-41FA-BC71-51C0FCF53221

P356

Q33591146-351FE20B-3F17-4A66-9586-9EE82B4F7BB4

P407

Q33591146-4BDC06F6-C514-44C9-8E97-E22E3EA9AA58

P433

Q33591146-CED2A1A4-A9BB-4A62-829E-AF880DBA8412

P478

Q33591146-A180C150-AE3B-4D58-ACC8-2583D5814282

P50

Q33591146-3C67EB2C-D1F0-4A4C-9C1A-F576CB9BB100

Q33591146-63E498B2-9825-4A3F-A3C2-21AA56113263

Q33591146-65B7DB60-4E32-4417-BA30-8246423FA05B

Q33591146-6A15F02C-BAA9-4FFC-8567-A91E276CDCEE

Q33591146-81F33E89-D39F-416E-8B0A-F688EA5CA1CE

Q33591146-8E1975FD-411E-4486-AA83-15FEBDA05F6B

Q33591146-E1D82F84-2D88-48FC-B635-D527C0AA5865

Q33591146-ED124013-C4F0-4353-B5CB-E3E0ADBC24F4

Q33591146-F2AD1379-4D79-4E35-9BF2-2240B2A65154

P577

Q33591146-71991334-A2F1-4794-B647-F62CBCB1D13B

P5875

Q33591146-C0BB1C23-7845-42D4-9750-803D16A7B454

P698

Q33591146-3106C405-23AC-461F-B849-981ECE20819E

P921

Q33591146-D751258E-3859-4DCA-A70F-DC70CFD230B9

P932

Q33591146-F215D667-D8B3-4291-94A9-3919A13DAA82

P356

JOURNAL.PONE.0096955

P1433

P1476

Assessment of metabolomic and ...... tion in chronic kidney disease

@en

P2093

Christian Delles

http://www.w3.org/2001/XMLSchema#string

Esther Nkuipou-Kenfack

http://www.w3.org/2001/XMLSchema#string

Holger Husi

http://www.w3.org/2001/XMLSchema#string

Mohammed Dakna

http://www.w3.org/2001/XMLSchema#string

Nathalie Gayrard

http://www.w3.org/2001/XMLSchema#string

Thomas Koeck

http://www.w3.org/2001/XMLSchema#string

Ulrika Lundin

http://www.w3.org/2001/XMLSchema#string

Àngel Argilés

http://www.w3.org/2001/XMLSchema#string

P2860

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis

Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry.

Urinary uromodulin excretion predicts progression of chronic kidney disease resulting from IgA nephropathy.

MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers.

Biomarker discovery and clinical proteomics.

Acyl-CoA synthesis, lipid metabolism and lipotoxicity.

MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes.

Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.

P304

e96955

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0096955

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Christian Delles

Klaus M Weinberger

P577

2014-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262228641

http://www.w3.org/2001/XMLSchema#string

P698

24817014

http://www.w3.org/2001/XMLSchema#string

P921

P932

4016198

http://www.w3.org/2001/XMLSchema#string